INTERCEPT PHARMACEUTICALS, INC. Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for May 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 9.82 | 973 | 9,557 | 2,056 | |
| May 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Sell | S | 260.20 | 973 | 253,175 | 962 | 1.9 K to 962 (-50.28 %) |
| May 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 9.82 | 973 | 9,557 | 1,935 | 962 to 1.9 K (+101.14 %) |
| May 22 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 21.50 | 1,000 | 21,500 | 5,249 | |
| May 22 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 21.50 | 1,000 | 21,500 | 8,642 | 7.6 K to 8.6 K (+13.09 %) |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 29,794 | |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 307.60 | 1,984 | 610,274 | 18,514 | 20.5 K to 18.5 K (-9.68 %) |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 306.31 | 2,295 | 702,970 | 20,498 | 22.8 K to 20.5 K (-10.07 %) |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,793 | 19.3 K to 22.8 K (+18.14 %) |
| May 18 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 5,000 | 43,334 | 129,128 | |
| May 18 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 300.00 | 5,000 | 1,500,000 | 495,743 | 500.7 K to 495.7 K (-1.00 %) |
| May 18 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 5,000 | 43,334 | 500,743 | 495.7 K to 500.7 K (+1.01 %) |
| May 13 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 391 | 8,407 | 8,363 | |
| May 13 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 283.33 | 233 | 66,016 | 2,166 | 2.4 K to 2.2 K (-9.71 %) |
| May 13 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 272.79 | 158 | 43,101 | 2,399 | 2.6 K to 2.4 K (-6.18 %) |
| May 13 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 391 | 8,407 | 2,557 | 2.2 K to 2.6 K (+18.05 %) |
| May 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 8.67 | 4,000 | 34,667 | 0 | |
| May 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 262.00 | 200 | 52,400 | 10,060 | 10.3 K to 10.1 K (-1.95 %) |
| May 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 261.05 | 1,000 | 261,045 | 10,260 | 11.3 K to 10.3 K (-8.88 %) |
| May 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 260.00 | 1,000 | 260,000 | 11,260 | 12.3 K to 11.3 K (-8.16 %) |
| May 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 259.12 | 1,800 | 466,418 | 12,260 | 14.1 K to 12.3 K (-12.80 %) |
| May 08 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 8.67 | 4,000 | 34,667 | 14,060 | 10.1 K to 14.1 K (+39.76 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 12,500 | 108,334 | 134,128 | |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 259.33 | 312 | 80,912 | 495,743 | 496.1 K to 495.7 K (-0.06 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 258.50 | 400 | 103,400 | 496,055 | 496.5 K to 496.1 K (-0.08 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 256.42 | 200 | 51,283 | 496,455 | 496.7 K to 496.5 K (-0.04 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 255.49 | 661 | 168,881 | 496,655 | 497.3 K to 496.7 K (-0.13 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 254.63 | 1,539 | 391,881 | 497,316 | 498.9 K to 497.3 K (-0.31 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 253.53 | 4,338 | 1,099,791 | 498,855 | 503.2 K to 498.9 K (-0.86 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 252.53 | 3,350 | 845,979 | 503,193 | 506.5 K to 503.2 K (-0.66 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 251.39 | 1,700 | 427,368 | 506,543 | 508.2 K to 506.5 K (-0.33 %) |
| May 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 12,500 | 108,334 | 508,243 | 495.7 K to 508.2 K (+2.52 %) |